Article Text

PDF
Octreotide in malignant chylothorax: a case report
  1. Ajay Gupta1 and
  2. Taranjit Singh2
  1. 1Department of Medical Oncology, Asian Cancer Center, Faridabad, India
  2. 2Department of Medical Oncology, Artemis Cancer Hospital, Gurgaon, India
  1. Correspondence to Dr Ajay Gupta, Department of Medical Oncology, Asian Cancer Center, Faridabad, India; Ajayajaygupta2002{at}rediffmail.com

Abstract

The treatment of malignancy-associated chylous pleural effusion and ascites, especially in the palliative setting, represents a major therapeutic challenge. Our patient, a case of metastatic lung cancer, was suffering from high-output, non-resolving, malignancy-related chylothorax. We found that subcutaneous octreotide in combination with fasting and total parenteral nutrition, followed later by institution of low-fat diet, resulted in its resolution. We suggest that it is a reasonable approach associated with minimal morbidity in what is otherwise a challenging clinical condition.

  • Drug administration
  • Clinical decisions
  • Hospital care
  • Supportive care

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.